{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:36:48Z","timestamp":1772890608629,"version":"3.50.1"},"reference-count":88,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","sleep.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine Clinics"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jsmc.2017.03.004","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T09:00:56Z","timestamp":1496048456000},"page":"279-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Immune Basis of\u00a0Narcolepsy"],"prefix":"10.1016","volume":"12","author":[{"given":"Shahrad","family":"Taheri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsmc.2017.03.004_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev.genom.4.070802.110432","article-title":"The genetics of narcolepsy","volume":"4","author":"Chabas","year":"2003","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"Suppl","key":"10.1016\/j.jsmc.2017.03.004_bib2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nn944","article-title":"Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders","volume":"5","author":"Mignot","year":"2002","journal-title":"Nat Neurosci"},{"issue":"3","key":"10.1016\/j.jsmc.2017.03.004_bib3","first-page":"203","article-title":"The genetics of sleep disorders","volume":"95","author":"Taheri","year":"2004","journal-title":"Minerva Med"},{"issue":"4","key":"10.1016\/j.jsmc.2017.03.004_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1474-4422(02)00103-5","article-title":"The genetics of sleep disorders","volume":"1","author":"Taheri","year":"2002","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jsmc.2017.03.004_bib5","series-title":"International classification of sleep disorders","author":"American Academy of Sleep Medicine","year":"2014"},{"key":"10.1016\/j.jsmc.2017.03.004_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.neuro.25.112701.142826","article-title":"The role of hypocretins (orexins) in sleep regulation and narcolepsy","volume":"25","author":"Taheri","year":"2002","journal-title":"Annu Rev Neurosci"},{"issue":"4","key":"10.1016\/j.jsmc.2017.03.004_bib7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-2265.2001.01247.x","article-title":"Orexins\/hypocretins: waking up the scientific world","volume":"54","author":"Taheri","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.jsmc.2017.03.004_bib8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1017\/S0033291701004949","article-title":"The orexins\/hypocretins: hypothalamic peptides linked to sleep and appetite","volume":"32","author":"Taheri","year":"2002","journal-title":"Psychol Med"},{"issue":"1","key":"10.1016\/j.jsmc.2017.03.004_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-5793(99)01030-3","article-title":"Distribution and quantification of immunoreactive orexin A in rat tissues","volume":"457","author":"Taheri","year":"1999","journal-title":"FEBS Lett"},{"issue":"9206","key":"10.1016\/j.jsmc.2017.03.004_bib10","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0140-6736(05)72463-6","article-title":"Role of orexins in sleep and arousal mechanisms","volume":"355","author":"Taheri","year":"2000","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.jsmc.2017.03.004_bib11","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1523\/JNEUROSCI.5560-03.2004","article-title":"Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat","volume":"24","author":"Beuckmann","year":"2004","journal-title":"J\u00a0Neurosci"},{"issue":"1","key":"10.1016\/j.jsmc.2017.03.004_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0167-0115(99)00076-2","article-title":"Orexins and orexin receptors: implication in feeding behavior","volume":"85","author":"Sakurai","year":"1999","journal-title":"Regul Pept"},{"issue":"4","key":"10.1016\/j.jsmc.2017.03.004_bib13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jsmc.2017.03.004_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5665\/sleep.2366","article-title":"High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy","volume":"36","author":"Poli","year":"2013","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.jsmc.2017.03.004_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.jsmc.2017.03.004_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A\u00a0mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.jsmc.2017.03.004_bib17","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archneur.59.10.1553","article-title":"The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias","volume":"59","author":"Mignot","year":"2002","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.jsmc.2017.03.004_bib18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.1130","article-title":"Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy","volume":"50","author":"Nishino","year":"2001","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.jsmc.2017.03.004_bib19","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1212\/WNL.57.12.2253","article-title":"CSF hypocretin\/orexin levels in narcolepsy and other neurological conditions","volume":"57","author":"Ripley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jsmc.2017.03.004_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5664\/jcsm.6454","article-title":"Normal morning MCH levels and no association with REM or NREM sleep parameters in narcolepsy type 1 and type 2","volume":"13","author":"Schrolkamp","year":"2016","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"3","key":"10.1016\/j.jsmc.2017.03.004_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"issue":"2\u20133","key":"10.1016\/j.jsmc.2017.03.004_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12026-014-8513-4","article-title":"History of narcolepsy at Stanford University","volume":"58","author":"Mignot","year":"2014","journal-title":"Immunol Res"},{"issue":"4","key":"10.1016\/j.jsmc.2017.03.004_bib23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1101\/gr.GR-1610R","article-title":"Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines","volume":"11","author":"Hungs","year":"2001","journal-title":"Genome Res"},{"key":"10.1016\/j.jsmc.2017.03.004_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1749-6632.1988.tb27056.x","article-title":"Narcolepsy and HLA in the Japanese","volume":"540","author":"Juji","year":"1988","journal-title":"Ann N Y Acad Sci"},{"issue":"1\u20132","key":"10.1016\/j.jsmc.2017.03.004_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-5728(01)00333-2","article-title":"Narcolepsy and the HLA region","volume":"117","author":"Lin","year":"2001","journal-title":"J\u00a0Neuroimmunol"},{"issue":"8","key":"10.1016\/j.jsmc.2017.03.004_bib26","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/01.WNL.0000168173.71940.ab","article-title":"Concomitant loss of dynorphin, NARP, and orexin in narcolepsy","volume":"65","author":"Crocker","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jsmc.2017.03.004_bib27","series-title":"The orexin\/hypocretin system: physiology and pathophysiology","first-page":"341","article-title":"Narcolepsy and autoimmunity","author":"Taheri","year":"2006"},{"issue":"5","key":"10.1016\/j.jsmc.2017.03.004_bib28","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.conb.2013.04.013","article-title":"The autoimmune basis of narcolepsy","volume":"23","author":"Mahlios","year":"2013","journal-title":"Curr Opin Neurobiol"},{"issue":"2","key":"10.1016\/j.jsmc.2017.03.004_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.smrv.2007.07.010","article-title":"Narcolepsy: immunological aspects","volume":"12","author":"Overeem","year":"2008","journal-title":"Sleep Med Rev"},{"issue":"1 Pt 2","key":"10.1016\/j.jsmc.2017.03.004_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/sleep\/9.1.143","article-title":"Immune factors in narcolepsy","volume":"9","author":"Langdon","year":"1986","journal-title":"Sleep"},{"issue":"6517","key":"10.1016\/j.jsmc.2017.03.004_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/bmj.292.6517.359","article-title":"Narcolepsy and immunity","volume":"292","author":"Parkes","year":"1986","journal-title":"Br Med J (clin Res Ed)"},{"issue":"8","key":"10.1016\/j.jsmc.2017.03.004_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1098\/rsob.160165","article-title":"Human leukocyte antigen-DM polymorphisms in autoimmune diseases","volume":"6","author":"Alvaro-Benito","year":"2016","journal-title":"Open Biol"},{"key":"10.1016\/j.jsmc.2017.03.004_bib33","series-title":"Narcolepsy: a clinical guide","first-page":"1","article-title":"The genetics of narcolepsy","author":"Taheri","year":"2016"},{"issue":"3","key":"10.1016\/j.jsmc.2017.03.004_bib34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0198-8859(87)90102-9","article-title":"Possible male segregation distortion of DR2 haplotypes in narcolepsy patients","volume":"20","author":"Mueller-Eckhardt","year":"1987","journal-title":"Hum Immunol"},{"issue":"6","key":"10.1016\/j.jsmc.2017.03.004_bib35","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/BF00430317","article-title":"DNA polymorphism related to HLA-DR2 Dw2 in patients with narcolepsy","volume":"22","author":"Marcadet","year":"1985","journal-title":"Immunogenetics"},{"issue":"12","key":"10.1016\/j.jsmc.2017.03.004_bib36","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1212\/WNL.37.12.1858","article-title":"HLA antigens in narcolepsy","volume":"37","author":"Neely","year":"1987","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jsmc.2017.03.004_bib37","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1073\/pnas.0308458100","article-title":"Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy","volume":"101","author":"Siebold","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jsmc.2017.03.004_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1399-0039.1998.tb02952.x","article-title":"HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group","volume":"51","author":"Pelin","year":"1998","journal-title":"Tissue Antigens"},{"issue":"1","key":"10.1016\/j.jsmc.2017.03.004_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/sleep\/33.1.29","article-title":"Does narcolepsy symptom severity vary according to HLA-DQB1*0602 allele status?","volume":"33","author":"Watson","year":"2010","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.jsmc.2017.03.004_bib40","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/318799","article-title":"Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups","volume":"68","author":"Mignot","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.jsmc.2017.03.004_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.humimm.2006.10.006","article-title":"DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans","volume":"68","author":"Hong","year":"2007","journal-title":"Hum Immunol"},{"issue":"3","key":"10.1016\/j.jsmc.2017.03.004_bib42","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5665\/sleep.5532","article-title":"Narcolepsy-associated HLA class I alleles implicate cell-mediated cytotoxicity","volume":"39","author":"Tafti","year":"2016","journal-title":"Sleep"},{"issue":"10","key":"10.1016\/j.jsmc.2017.03.004_bib43","doi-asserted-by":"crossref","first-page":"e1003880","DOI":"10.1371\/journal.pgen.1003880","article-title":"Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic","volume":"9","author":"Han","year":"2013","journal-title":"PLoS Genet"},{"issue":"6","key":"10.1016\/j.jsmc.2017.03.004_bib44","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ng.372","article-title":"Narcolepsy is strongly associated with the T-cell receptor alpha locus","volume":"41","author":"Hallmayer","year":"2009","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.jsmc.2017.03.004_bib45","doi-asserted-by":"crossref","first-page":"e1003270","DOI":"10.1371\/journal.pgen.1003270","article-title":"ImmunoChip study implicates antigen presentation to T cells in narcolepsy","volume":"9","author":"Faraco","year":"2013","journal-title":"PLoS Genet"},{"issue":"3","key":"10.1016\/j.jsmc.2017.03.004_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.sleep.2011.06.020","article-title":"TCRA, P2RY11, and CPT1B\/CHKB associations in Chinese narcolepsy","volume":"13","author":"Han","year":"2012","journal-title":"Sleep Med"},{"issue":"10","key":"10.1016\/j.jsmc.2017.03.004_bib47","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/hmg\/dds035","article-title":"Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy","volume":"21","author":"Winkelmann","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1016\/j.jsmc.2017.03.004_bib48","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/ejhg.2015.4","article-title":"EIF3G is associated with narcolepsy across ethnicities","volume":"23","author":"Holm","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jsmc.2017.03.004_bib49","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bbi.2015.05.003","article-title":"A\u00a0polymorphism in CCR1\/CCR3 is associated with narcolepsy","volume":"49","author":"Toyoda","year":"2015","journal-title":"Brain Behav Immun"},{"issue":"8","key":"10.1016\/j.jsmc.2017.03.004_bib50","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/sleep\/32.8.979","article-title":"Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset","volume":"32","author":"Aran","year":"2009","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.jsmc.2017.03.004_bib51","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/joim.12355","article-title":"Increased beta-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases","volume":"278","author":"Ambati","year":"2015","journal-title":"J\u00a0Intern Med"},{"issue":"4","key":"10.1016\/j.jsmc.2017.03.004_bib52","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.23799","article-title":"Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic","volume":"73","author":"Han","year":"2013","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.jsmc.2017.03.004_bib53","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.22587","article-title":"Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China","volume":"70","author":"Han","year":"2011","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.jsmc.2017.03.004_bib54","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1474-4422(14)70075-4","article-title":"Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination","volume":"13","author":"Partinen","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jsmc.2017.03.004_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.01.033","article-title":"Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants","volume":"50","author":"Ahmed","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jsmc.2017.03.004_bib56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbi.2014.11.004","article-title":"Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development","volume":"47","author":"Jacob","year":"2015","journal-title":"Brain Behav Immun"},{"issue":"12","key":"10.1016\/j.jsmc.2017.03.004_bib57","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1080\/21645515.2016.1171439","article-title":"Mechanistic insights into influenza vaccine-associated narcolepsy","volume":"12","author":"Ahmed","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jsmc.2017.03.004_bib58","first-page":"A285","article-title":"Investigation of the autoimmune basis of narcolepsy using western blot analysis of lateral hypothalamus protein extract with serum and cerebrospinal fluid (CSF)","author":"Taheri","year":"2003","journal-title":"Sleep"},{"issue":"1\u20132","key":"10.1016\/j.jsmc.2017.03.004_bib59","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jneuroim.2006.02.010","article-title":"Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy","volume":"174","author":"Overeem","year":"2006","journal-title":"J\u00a0Neuroimmunol"},{"issue":"35","key":"10.1016\/j.jsmc.2017.03.004_bib60","doi-asserted-by":"crossref","first-page":"E3735","DOI":"10.1073\/pnas.1412189111","article-title":"Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns","volume":"111","author":"Bergman","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jsmc.2017.03.004_bib61","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jneuroim.2015.04.008","article-title":"Immunohistochemical screening for antibodies in recent onset type 1 narcolepsy and after H1N1 vaccination","volume":"283","author":"van der Heide","year":"2015","journal-title":"J\u00a0Neuroimmunol"},{"issue":"6","key":"10.1016\/j.jsmc.2017.03.004_bib62","doi-asserted-by":"crossref","first-page":"e0129555","DOI":"10.1371\/journal.pone.0129555","article-title":"Neuronal antibodies in children with or without narcolepsy following H1N1-AS03 vaccination","volume":"10","author":"Thebault","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jsmc.2017.03.004_bib63","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1212\/01.WNL.0000081049.14098.50","article-title":"CSF hypocretin levels in Guillain-Barre syndrome and other inflammatory neuropathies","volume":"61","author":"Nishino","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jsmc.2017.03.004_bib64","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaut.2015.07.006","article-title":"Autoantibodies against ganglioside GM3 are associated\u00a0with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus","volume":"63","author":"Saariaho","year":"2015","journal-title":"J\u00a0Autoimmun"},{"issue":"294","key":"10.1016\/j.jsmc.2017.03.004_bib65","doi-asserted-by":"crossref","first-page":"294ra105","DOI":"10.1126\/scitranslmed.aab2354","article-title":"Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2","volume":"7","author":"Ahmed","year":"2015","journal-title":"Sci Transl Med"},{"issue":"314","key":"10.1016\/j.jsmc.2017.03.004_bib66","doi-asserted-by":"crossref","first-page":"314le2","DOI":"10.1126\/scitranslmed.aad2353","article-title":"Comment on \u201cAntibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2\u201d","volume":"7","author":"Vassalli","year":"2015","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.jsmc.2017.03.004_bib67","first-page":"1305","article-title":"Hypothalamic immunopathology in anti-Ma-associated diencephalitis with narcolepsy-cataplexy","volume":"70","author":"Dauvilliers","year":"2013","journal-title":"JAMA Neurol"},{"issue":"39","key":"10.1016\/j.jsmc.2017.03.004_bib68","doi-asserted-by":"crossref","first-page":"10956","DOI":"10.1073\/pnas.1603325113","article-title":"CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice","volume":"113","author":"Bernard-Valnet","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.jsmc.2017.03.004_bib69","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI41366","article-title":"Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients","volume":"120","author":"Cvetkovic-Lopes","year":"2010","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.jsmc.2017.03.004_bib70","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/sleep\/33.7.875","article-title":"Anti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy","volume":"33","author":"Toyoda","year":"2010","journal-title":"Sleep"},{"issue":"7","key":"10.1016\/j.jsmc.2017.03.004_bib71","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/sleep\/33.7.869","article-title":"Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy","volume":"33","author":"Kawashima","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.jsmc.2017.03.004_bib72","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2013.06.010","article-title":"Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice","volume":"45","author":"Katzav","year":"2013","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1016\/j.jsmc.2017.03.004_bib73","article-title":"Anti-tribbles pseudokinase 2 (TRIB2)-immunization modulates HYPOCRETIN\/OREXIN neuronal functions","volume":"40","author":"Tanaka","year":"2017","journal-title":"Sleep"},{"key":"10.1016\/j.jsmc.2017.03.004_bib74","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5664\/jcsm.6500","article-title":"Intravenous immunoglobulin therapy in pediatric narcolepsy: a nonrandomized, open-label, controlled, longitudinal observational study","volume":"13","author":"Lecendreux","year":"2017","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.jsmc.2017.03.004_bib75","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2869.2003.00380.x","article-title":"Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy","volume":"12","author":"Lecendreux","year":"2003","journal-title":"J\u00a0Sleep Res"},{"issue":"16","key":"10.1016\/j.jsmc.2017.03.004_bib76","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.0b013e3181bd1344","article-title":"Normalization of\u00a0hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment","volume":"73","author":"Dauvilliers","year":"2009","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jsmc.2017.03.004_bib77","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.20339","article-title":"Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset","volume":"56","author":"Dauvilliers","year":"2004","journal-title":"Ann Neurol"},{"issue":"Suppl 5","key":"10.1016\/j.jsmc.2017.03.004_bib78","first-page":"V25","article-title":"Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects","volume":"253","author":"Dalakas","year":"2006","journal-title":"J\u00a0Neurol"},{"issue":"2","key":"10.1016\/j.jsmc.2017.03.004_bib79","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/dmcn.13349","article-title":"Systematic review of immunoglobulin use in paediatric neurological and neurodevelopmental disorders","volume":"59","author":"Gadian","year":"2017","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.jsmc.2017.03.004_bib80","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1212\/WNL.0b013e31825dce03","article-title":"Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency","volume":"79","author":"Knudsen","year":"2012","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jsmc.2017.03.004_bib81","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-0030-1267993","article-title":"Intravenous immunoglobulin treatment and screening for hypocretin neuron-specific autoantibodies in recent onset childhood narcolepsy with cataplexy","volume":"41","author":"Knudsen","year":"2010","journal-title":"Neuropediatrics"},{"issue":"10","key":"10.1016\/j.jsmc.2017.03.004_bib82","first-page":"1549","article-title":"Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy","volume":"255","author":"Plazzi","year":"2008","journal-title":"J\u00a0Neurol"},{"issue":"7","key":"10.1016\/j.jsmc.2017.03.004_bib83","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/sleep\/26.7.809","article-title":"Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy","volume":"26","author":"Hecht","year":"2003","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.jsmc.2017.03.004_bib84","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0404.1990.tb00978.x","article-title":"CSF immune variables in patients with narcolepsy","volume":"81","author":"Fredrikson","year":"1990","journal-title":"Acta Neurol Scand"},{"issue":"11","key":"10.1016\/j.jsmc.2017.03.004_bib85","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S1474-4422(14)70168-1","article-title":"Does autoreactivity have a role in narcolepsy?","volume":"13","author":"Partinen","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jsmc.2017.03.004_bib86","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/nyas.12793","article-title":"Type 1 narcolepsy: a CD8(+) T cell-mediated disease?","volume":"1351","author":"Degn","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jsmc.2017.03.004_bib87","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbi.2015.03.004","article-title":"Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset","volume":"49","author":"Kornum","year":"2015","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.jsmc.2017.03.004_bib88","article-title":"Cerebrospinal fluid biomarkers of neurodegeneration are decreased or normal in narcolepsy","volume":"40","author":"Jennum","year":"2017","journal-title":"Sleep"}],"container-title":["Sleep Medicine Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556407X17300152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556407X17300152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T07:50:58Z","timestamp":1535788258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556407X17300152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1556407X17300152"],"URL":"https:\/\/doi.org\/10.1016\/j.jsmc.2017.03.004","relation":{},"ISSN":["1556-407X"],"issn-type":[{"value":"1556-407X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Immune Basis of\u00a0Narcolepsy","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsmc.2017.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}